Skip to content

Study on biomechanical mechanism and efficacy evaluation of Wei's two-step seven method for treatment of lumbar disc herniation

Study on biomechanical mechanism and efficacy evaluation of Wei's two-step seven method for treatment of lumbar disc herniation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005733
Enrollment
Unknown
Registered
2022-03-16
Start date
2022-03-17
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation

Interventions

treatment group:Wei's two-step seven manipulation
control group:Traditional massage techniques

Sponsors

The Ruijin Hospital Afiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria, including clinical signs and imaging data, among which the diagnostic criteria of TCM: refer to the diagnostic criteria of LDH in the Diagnostic and Therapeutic Criteria of TCM Diseases and Syndromes; Western diagnostic criteria: refer to the relevant content of the Chinese expert consensus on the diagnosis and treatment of lumbar disc herniation. 2) Sign informed consent with date, promise to abide by the study procedure, and cooperate with the implementation of the whole process of the study. 3) Aged 18-65. 4) Agree to receive treatment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Unable to cooperate with the completion of data collection or incomplete data; 2) Patients with lumbar vertebrae fracture or local bone diseases such as tuberculosis and tumor; 3) Patients with serious primary diseases such as cardiovascular, liver, kidney or hematopoietic system, other autoimmune diseases, allergic diseases and acute or chronic infected persons; 4) Psychiatric patients, or women with severe menopausal symptoms; 5) Pregnant or lactating women; 6) Experimental studies of other therapies for this disease are under way within 2 weeks.

Design outcomes

Primary

MeasureTime frame
/;/;/;

Countries

china

Contacts

Public Contactxuebin

The Ruijin Hospital Afiliated to Shanghai Jiao Tong University School of Medicine

skxuebin@163.com18817821387

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026